Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Insurance Stocks to Buy Following Q1 Earnings

In this article, we will discuss the 5 Best Insurance Stocks to Buy Following Q1 Earnings. For deeper discussion and analysis, read 10 Best Insurance Stocks to Buy Following Q1 Earnings.

5. Fidelity National Financial, Inc. (NYSE:FNF)

Target Price: $46.47 

Upside Potential: 33.85% 

On May 12, Stephens lowered its price target on Fidelity National Financial, Inc. (NYSE:FNF) to $58 from $61 while maintaining an Overweight rating on the shares. The firm noted that Fidelity delivered solid first-quarter results, demonstrating resilience despite ongoing challenges in the housing and mortgage markets. However, Stephens adjusted its near-term outlook to account for increased uncertainty surrounding interest rate expectations and a slower-than-anticipated recovery in residential real estate activity.

On May 11, Barclays analyst Terry Ma reduced the firm’s price target on Fidelity National Financial, Inc. (NYSE:FNF) to $50 from $54 while maintaining an Equal Weight rating on the stock. The revised target reflects a more cautious outlook for the operating environment as market participants continue to assess the impact of interest rates and housing market conditions on transaction volumes and industry activity.

Incorporated in 1984, Fidelity National Financial, Inc. (NYSE:FNF) is headquartered in Jacksonville, Florida. As the nation’s largest title insurance company, it primarily provides title insurance, escrow, and settlement services to the real estate and mortgage industries, while also offering select annuity and life insurance products.

4. Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Target Price: $41.89 

Upside Potential: 35.74% 

Ryan Specialty Holdings, Inc. (NYSE:RYAN) attracted mixed but noteworthy analyst attention on June 8 when Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to $35 from $42. The firm cited expectations for a prolonged period of commercial property and casualty insurance pricing moderation, which could make it more difficult for the company to achieve consensus forecasts for accelerating organic growth in future years. Despite the downgrade, Goldman acknowledged that Ryan Specialty remains a leading participant in the specialty insurance market, with concerns centered primarily on growth expectations rather than the quality of the underlying business.

Previously, on May 27, Keefe Bruyette raised its price target on Ryan Specialty Holdings, Inc. (NYSE:RYAN) to $44 from $42 while maintaining an Outperform rating. The firm viewed the company’s decision to increase its share repurchase authorization by $300 million as a strong signal of management’s confidence in its financial position, cash-generation capabilities, and long-term growth prospects. The expanded buyback program highlights Ryan Specialty’s ability to return capital to shareholders while continuing to invest in its business and strategic growth initiatives.

Founded in 2010 and headquartered in Chicago, Illinois, Ryan Specialty Holdings, Inc. (NYSE:RYAN) is an international specialty insurance organization that operates as a wholesale broker and managing underwriter. The company provides specialized distribution, underwriting, product development, and risk-management services for complex or difficult-to-place insurance risks.

3. James River Group Holdings, Inc. (NASDAQ:JRVR)

Target Price: $5.38 

Upside Potential: 35.86% 

On May 19, UBS downgraded James River Group Holdings, Inc. (NASDAQ:JRVR) to Neutral from Buy and reduced its price target to $4.75 from $8.00. The firm cited a higher cost of equity capital stemming from increased risks related to adverse reserve development. UBS also noted that intensifying competition within the small- to middle-market excess and surplus lines sector could make it more difficult for the company to achieve meaningful growth, leading the analyst to adopt a more cautious stance on the shares.

Previously, on May 5, Citizens downgraded James River Group Holdings, Inc. (NASDAQ:JRVR) to Market Perform from Outperform without assigning a price target. The firm pointed to disappointing first-quarter results and highlighted that the company utilized approximately two-thirds of its remaining excess and surplus adverse development cover limit, leaving only $7.5 million available for potential future adverse development. According to the analyst, the reduced protection weakens a key risk-mitigation mechanism that had previously provided investors with greater confidence regarding reserve-related exposures.

Founded in 2002 and headquartered in Pembroke, Bermuda, James River Group Holdings, Inc. (NASDAQ:JRVR) is an insurance holding company that owns and operates a group of specialty property-casualty insurance and reinsurance companies, operating primarily in the U.S. excess and surplus (E&S) lines market.

2. Abacus Global Management, Inc. (NYSE:ABX)

Target Price: $13.64 

Upside Potential: 64.14% 

On May 27, Abacus Global Management, Inc. (NYSE:ABX) and Manning & Napier announced the formation of a strategic alliance agreement alongside the completion of Abacus’s minority equity investment in Manning & Napier. Through the transaction, Abacus joins Callodine Group and East Asset Management as an institutional investor in the firm. The partnership is intended to create value across several key areas, including lead generation and referral opportunities, product development and distribution initiatives, and the delivery of integrated client solutions. The agreement establishes a framework for ongoing collaboration between the two organizations and is expected to enhance the capabilities and reach of their respective platforms.

On May 8, Piper Sandler analyst Crispin Love raised the firm’s price target on Abacus Global Management, Inc. (NYSE:ABX) to $10 from $9.50 while maintaining a Neutral rating on the shares. The firm noted that the company delivered core results that exceeded its internal expectations, although performance came in slightly below broader market estimates. Importantly, Abacus increased its 2026 guidance, raising the midpoint of its adjusted net income forecast to $103 million from the previous midpoint of $100 million, reflecting management’s confidence in the company’s earnings trajectory and business momentum.

Founded in 2004 and headquartered in Orlando, Florida, Abacus Global Management, Inc. (NYSE:ABX) is a financial services firm that specializes in alternative asset management, data-driven wealth solutions, life settlements, and life insurance-related technology innovations.

1. Exzeo Group, Inc. (NYSE:XZO)

Target Price: $26 

Upside Potential: 94.18% 

On May 26, Exzeo Group, Inc. (NYSE:XZO) announced that its Board of Directors authorized a new share repurchase program and adopted a corresponding Rule 10b5-1 trading plan to acquire up to $12 million of the company’s common stock, subject to market conditions. The authorization became effective immediately and reflects management’s confidence in the company’s long-term prospects, while providing an additional mechanism to return value to shareholders and potentially enhance earnings per share over time.

On May 6, Exzeo Group, Inc. (NYSE:XZO) reported first-quarter revenue of $55.53 million compared with consensus expectations of $58.06 million. Despite the revenue shortfall, management highlighted continued momentum across the Exzeo platform, including strong growth in managed premiums and the addition of a seventh insurance carrier partner. Chairman and Chief Executive Officer Paresh Patel stated that the company has successfully executed on several strategic priorities since its initial public offering, including driving profitable growth with existing carrier partners, expanding relationships with third-party clients, and advancing product innovation throughout its platform. The company’s progress underscores its focus on scaling operations and strengthening its position within the insurtech market.

Founded in 2012 and headquartered in Tampa, Florida, Exzeo Group, Inc. (NYSE:XZO) is an insurtech company that provides software and analytics tools. It develops an Insurance-as-a-Service (IaaS) platform that helps property and casualty insurers manage operations such as quoting, underwriting, claims processing, and policy management.

While we acknowledge the potential of XZO as an insurance stock, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than XZO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Best 3D Printing Stocks to Buy for Aerospace Components and Top 10 Stocks That Members of Congress Own.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.